Related Experiment Video
Updated: Mar 15, 2026
09:16
Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
20.6K
A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson's
Valentina La Cognata1,2, Giovanna Morello1, Giulia Gentile1
1Institute of Neurological Sciences, National Research Council, Catania, Italy.
Neurogenetics
|September 18, 2016
Summary
Parkinson's disease (PD) genetics are complex. A new high-resolution platform, NeuroArray, effectively detects copy number variations (CNVs) in PD-related genes, aiding in diagnosing inherited forms of the disease.
Area of Science:
- Neurogenetics
- Genomic Medicine
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder with a complex genetic basis.
- While initially considered sporadic, genetic factors, including Mendelian genes and risk factors, are increasingly recognized.
- Gene-dosage abnormalities and copy number variations (CNVs) are significant but challenging to detect causes of PD.
Purpose of the Study:
- To develop and validate a high-resolution platform for detecting CNVs in PD-related genes.
- To improve the diagnostic yield for inherited forms of Parkinson's disease.
- To facilitate the investigation of novel candidate genes associated with PD.
Main Methods:
- Design, development, and validation of NeuroArray, a customized exon-centric array-based comparative genomic hybridization (aCGH) platform.
- Targeted detection of single/multi-exon deletions and duplications in a panel of PD-related genes.
- Utilizing high-throughput platforms and bioinformatics algorithms for accurate CNV genotyping.
Main Results:
- NeuroArray provides exon-level resolution for detecting structural variations.
- The platform combines targeted analysis with genome-wide coverage.
- Successful validation of the NeuroArray platform for CNV detection in PD genes.
Conclusions:
- NeuroArray is an effective tool for identifying inherited structural alterations in Parkinson's disease.
- This platform can enhance the understanding of the genetic architecture of PD.
- NeuroArray may aid in discovering new PD-associated genes and improving patient diagnosis.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
19.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.0K
01:11Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K